265 related articles for article (PubMed ID: 11064618)
21. Spinal leptin contributes to the development of morphine antinociceptive tolerance by activating the STAT3-NMDA receptor pathway in rats.
Hu F; Cui Y; Guo R; Chen J; Guo R; Shen N; Hua X; Mo L; Feng J
Mol Med Rep; 2014 Aug; 10(2):923-30. PubMed ID: 24841769
[TBL] [Abstract][Full Text] [Related]
22. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
[TBL] [Abstract][Full Text] [Related]
23. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
24. The spinal nitric oxide involved in the inhibitory effect of midazolam on morphine-induced analgesia tolerance.
Cao JL; Ding HL; He JH; Zhang LC; Duan SM; Zeng YM
Pharmacol Biochem Behav; 2005 Mar; 80(3):493-503. PubMed ID: 15740792
[TBL] [Abstract][Full Text] [Related]
25. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
26. Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord.
Grisel JE; Watkins LR; Maier SF
Psychopharmacology (Berl); 1996 Dec; 128(3):248-55. PubMed ID: 8972544
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.
Bhargava HN; Reddy PL; Gudehithlu KP
Gen Pharmacol; 1995 Jan; 26(1):131-6. PubMed ID: 7713352
[TBL] [Abstract][Full Text] [Related]
28. MK-801 inhibits the development of morphine tolerance at spinal sites.
Gutstein HB; Trujillo KA
Brain Res; 1993 Oct; 626(1-2):332-4. PubMed ID: 8281446
[TBL] [Abstract][Full Text] [Related]
29. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain.
Zahn PK; Brennan TJ
Anesthesiology; 1998 Jan; 88(1):143-56. PubMed ID: 9447867
[TBL] [Abstract][Full Text] [Related]
30. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.
Mao J; Price DD; Mayer DJ
J Neurosci; 1994 Apr; 14(4):2301-12. PubMed ID: 7908958
[TBL] [Abstract][Full Text] [Related]
31. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance.
Powell KJ; Hosokawa A; Bell A; Sutak M; Milne B; Quirion R; Jhamandas K
Br J Pharmacol; 1999 Jun; 127(3):631-44. PubMed ID: 10401553
[TBL] [Abstract][Full Text] [Related]
33. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
[TBL] [Abstract][Full Text] [Related]
34. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
35. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine.
Mao J; Price DD; Phillips LL; Lu J; Mayer DJ
Brain Res; 1995 Apr; 677(2):257-67. PubMed ID: 7552251
[TBL] [Abstract][Full Text] [Related]
36. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
McNally GP; Westbrook RF
Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
[TBL] [Abstract][Full Text] [Related]
37. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
38. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain.
Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ
Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481
[TBL] [Abstract][Full Text] [Related]
39. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
Zhu H; Brodsky M; Gorman AL; Inturrisi CE
Brain Res Mol Brain Res; 2003 Jun; 114(2):154-62. PubMed ID: 12829326
[TBL] [Abstract][Full Text] [Related]
40. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats.
Luger TJ; Lorenz IH; Grabner-Weiss C; Hayashi T
Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
